Report copyright - Maintenance Therapy for Advanced NSCLC · Bevacizumab pemetrexed cisplatin q3w Previously untreated stage IIIB/IV nonsquamous NSCLC Bevacizumab (7.5mg/kg) q3w Bevacizumab (7.5mg/kg)
Please pass captcha verification before submit form